Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.

Pirodavir (R77975) is a capsid-binding, antipicornaviral agent with in vitro activity against most rhinovirus (RV) serotypes. We conducted four double-blind, controlled trials to assess the efficacy of intranasal pirodavir in experimentally induced RV infection of susceptible volunteers. Intranasal...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Hayden, F G, Andries, K, Janssen, P A
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1992
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189373/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1503435/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.727
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!